Cargando…

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient

We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Verwimp, J, Geurs, F, Ponette, S, Ponette, J, Martens, J, Bulté, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108765/
https://www.ncbi.nlm.nih.gov/pubmed/21694930
_version_ 1782205370275463168
author Verwimp, J
Geurs, F
Ponette, S
Ponette, J
Martens, J
Bulté, K
author_facet Verwimp, J
Geurs, F
Ponette, S
Ponette, J
Martens, J
Bulté, K
author_sort Verwimp, J
collection PubMed
description We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemotherapy with 5 fluorouracil and irinotecan. After six months of chemotherapy, liver scans show complete remission. The principles, practice, and experience of chemotherapy with irinotecan during dialysis are discussed.
format Online
Article
Text
id pubmed-3108765
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31087652011-06-21 Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient Verwimp, J Geurs, F Ponette, S Ponette, J Martens, J Bulté, K Int J Nephrol Renovasc Dis Case Report We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemotherapy with 5 fluorouracil and irinotecan. After six months of chemotherapy, liver scans show complete remission. The principles, practice, and experience of chemotherapy with irinotecan during dialysis are discussed. Dove Medical Press 2010-05-17 /pmc/articles/PMC3108765/ /pubmed/21694930 Text en © 2010 Verwimp et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Case Report
Verwimp, J
Geurs, F
Ponette, S
Ponette, J
Martens, J
Bulté, K
Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_full Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_fullStr Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_full_unstemmed Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_short Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
title_sort complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108765/
https://www.ncbi.nlm.nih.gov/pubmed/21694930
work_keys_str_mv AT verwimpj completeresponseofametastaticgastroesophagealadenocarcinomaonirinotecanbasedchemotherapyinadialysispatient
AT geursf completeresponseofametastaticgastroesophagealadenocarcinomaonirinotecanbasedchemotherapyinadialysispatient
AT ponettes completeresponseofametastaticgastroesophagealadenocarcinomaonirinotecanbasedchemotherapyinadialysispatient
AT ponettej completeresponseofametastaticgastroesophagealadenocarcinomaonirinotecanbasedchemotherapyinadialysispatient
AT martensj completeresponseofametastaticgastroesophagealadenocarcinomaonirinotecanbasedchemotherapyinadialysispatient
AT bultek completeresponseofametastaticgastroesophagealadenocarcinomaonirinotecanbasedchemotherapyinadialysispatient